Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BYFrontiers in medicine

Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records

  • Canchao Sun1
  • Juan Xu1
  • Tiye Sun1
  1. 1Tumor Center, Beijing Royal Integrative Medicine Hospital , ,
Read full textPDFCite

Related

  1. Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study
    Zizhuo Wang, Bailu Wu, Chunshu Wu +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  2. Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study
    Xiaolong Zhang, Jun Hu, Haoming Lan +3
    Journal of Hepatocellular CarcinomaPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  3. Early antibiotic exposure, but not late exposure, negatively affects the clinical outcomes of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma
    Aryoung Kim, Myung Ji Goh, Byeong Geun Song +6
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. A Case of Unresectable Hepatocellular Carcinoma Responding to Durvalumab Plus Tremelimumab after Lenvatinib Treatment
    Saki Sueda, Tomokazu Kawaoka, Yasutoshi Fujii +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Immune-mediated Myocarditis after Durvalumab/tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    Shogo Mawatari, Ryu Sasaki, Yasuhiko Nakao +4
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{sun2026survival,
  title = {{Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records}},
  author = {Canchao Sun and Juan Xu and Tiye Sun},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13672034},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records
AU  - Canchao Sun
AU  - Juan Xu
AU  - Tiye Sun
PY  - 2026
DA  - 2026/10/19
JO  - Frontiers in medicine
UR  - https://europepmc.org/article/PMC/PMC13672034
SN  - 2296-858X
ER  -